ÂÜÀòÂÒÂ×

Ibrahim Sahraoui currently serves as the Executive Director and Head of Quality Biologics at Lonza, overseeing a cross-functional team responsible for Quality Services in manufacturing. With a background in compliance systems at Novartis, including leadership roles in QA for sterile products and drug release for clinical trials, Ibrahim has extensive experience in quality assurance and regulatory compliance. Earlier roles at Ferring Pharmaceuticals, Delpharm, Sanofi-Aventis, and Guerbet provided valuable insights into automation, quality control, and regulatory affairs. Ibrahim holds a Doctorate in Pharmacy, an MBA, and an engineering degree in Chemical Engineering, all of which contribute to a robust expertise in the pharmaceutical industry.